János Szöllősi

János Szöllősi

Auto-generated profile, based on publicly available information

János Szöllősi

Department of Biophysics and Cell Biology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2008 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
ÁFÁkos Fábián
Ákos Fábián
MBMárk Barok
Márk Barok
GVGyörgy Vereb
György Vereb
JSJános Szöllősi
János Szöllősi
In recent years, an exponentially growing number of studies have focused on identifying cancer stem cells (CSC) in human malignancies. The rare CSCs could be crucial in controlling and curing cancer: through asymmetric division CSCs supposedly drive tumor growth and evade therapy with the help of traits shared with normal stem cells such as quiescence, self‐renewal ability, and multidrug resistance pump activity. Here, we give a brief overview of techniques used to confirm the stem cell‐like behavior of putative CSCs and discuss markers and methods for identifying, isolating, and culturing them. We touch on the limitations of each marker and why the combined use of CSC markers, in vitro and in vivo assays may still fail to identify all relevant CSC populations. Finally, the various experimental findings supporting and contradicting the CSC hypothesis are summarized. The large number of tumor types thus far with a subpopulation of uniquely tumorigenic and therapy resistant cells suggests that despite the unanswered questions and inconsistencies, the CSC hypothesis has a legitimate role to play in tumor biology. At the same time, experimental evidence supporting the established alternative theory of clonal evolution can be found as well. Therefore, a model that describes cancer initiation and progression should combine elements of clonal evolution and CSC theory. © 2008 International Society for Advancement of Cytometry

19 August 2008 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
Jason RoszikJason Roszik
Jason Roszik
JSJános Szöllősi
János Szöllősi
GVGyörgy Vereb
György Vereb
Background: The acceptor photobleaching fluorescence resonance energy transfer (FRET) method is widely used for monitoring molecular interactions in cells. This method of FRET, while among those with the simplest mathematics, is robust, self-controlled and independent of fluorophore amounts and ratios. Results: AccPbFRET is a user-friendly, efficient ImageJ plugin which allows fully corrected, pixel-wise calculation and detailed, ROI (region of interest)-based analysis of FRET efficiencies in microscopic images. Furthermore, automatic registration and semi-automatic analysis of large image sets is provided, which are not available in any existing FRET evaluation software. Conclusion: Despite of the widespread applicability of the acceptor photobleaching FRET technique, this is the first paper where all possible sources of major errors of the measurement and analysis are considered, and AccPbFRET is the only program which provides the complete suite of corrections – for registering image pairs, for unwanted photobleaching of the donor, for cross-talk of the acceptor and/or its photoproduct to the donor channel and for partial photobleaching of the acceptor. The program efficiently speeds up the analysis of large image sets even for novice users and is freely available.

28 November 2007 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
ZFZsolt Fazekas
Zsolt Fazekas
MPMiklós Petrás
Miklós Petrás
ÁFÁkos Fábián
Ákos Fábián
ZPZsuzsanna Pályi‐Krekk
Zsuzsanna Pályi‐Krekk
Peter NagyPeter Nagy
Peter Nagy
JSJános Szöllősi
János Szöllősi
The role of the expression patterns of proteins involved in oncogenesis can be understood after characterizing their multimolecular interactions. Conventional FRET methods permit the analysis of interaction between two molecular species at the most, which necessitates the introduction of new approaches for studying multicomponent signaling complexes. Flow cytometric as well as microscopic donor (dbFRET) and acceptor (abFRET) photobleaching FRET measurements were performed to determine the association states of ErbB2, β1‐integrin, and CD44 receptors. Based on consecutively applied abFRET and dbFRET methods (two‐sided FRET), the relationship of β1‐integrin–ErbB2 heteroassociation to ErbB2 homoassociation and of β1‐integrin–ErbB2 heteroassociation to ErbB2–CD44 heteroassociation was studied by correlating pixel‐by‐pixel FRET values of the corresponding abFRET and dbFRET images in contour plots. Anticorrelation was observed between β1‐integrin–ErbB2 heteroassociation and ErbB2 homoassociation on trastuzumab sensitive N87 and SK‐BR‐3 cells, while modest positive correlation was found between β1‐integrin–ErbB2 and ErbB2–CD44 heteroassociation on trastuzumab resistant MKN‐7 cells. The FRET efficiency values of β1‐integrin–ErbB2 heteroassociation were markedly higher at the focal adhesion regions on attached cells than those measured by flow cytometry on detached cells. In conclusion, we implemented an experimental set‐up termed two‐sided FRET for correlating two pairwise interactions of three arbitrarily chosen molecular species. On the basis of our results, we assume that the homoassociation state of ErbB2 is dynamically modulated by its interaction with β1‐integrins. © 2007 International Society for Analytical Cytology

10 March 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
Jason RoszikJason Roszik
Jason Roszik
ZSZsolt Sebestyén
Zsolt Sebestyén
CGCoen Govers
Coen Govers
YGYakir Guri
Yakir Guri
ÁSÁrpád Szöőr
Árpád Szöőr
RDReno Debets
Reno Debets
T‐cell receptors (TCRs) can be genetically modified to improve gene‐engineered T‐cell responses, a strategy considered critical for the success of clinical TCR gene therapy to treat cancers. TCR:ζ, which is a heterodimer of TCRα and β chains each coupled to complete human CD3ζ, overcomes issues of mis‐pairing with endogenous TCR chains, shows high surface expression and mediates antigen‐specific T‐cell functions in vitro. In the current study, we further characterized TCR:ζ in gene‐engineered T cells and assessed whether this receptor is able to interact with surface molecules and drive correct synapse formation in Jurkat T cells. The results showed that TCR:ζ mediates the formation of synaptic areas with antigen‐positive target cells, interacts closely with CD8α and MHC class I (MHCI), and co‐localizes with CD28, CD45 and lipid rafts, similar to WT TCR. TCR:ζ did not closely associate with endogenous CD3ε, despite its co‐presence in immune synapses, and TCR:ζ showed enhanced synaptic accumulation in T cells negative for surface‐expressed TCR molecules. Notably, synaptic TCR:ζ demonstrated lowered densities when compared with TCR in dual TCR T cells, a phenomenon that was related to both extracellular and intracellular CD3ζ domains present in the TCR:ζ molecule and responsible for enlarged synapse areas.

1 May 2008 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
Peter NagyPeter Nagy
Peter Nagy
JSJános Szöllősi
János Szöllősi

5 August 2009 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
Peter NagyPeter Nagy
Peter Nagy
JSJános Szöllősi
János Szöllősi